blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP4116324

EP4116324 - ADENOVIRUS IMMUNOASSAY METHOD AND ADENOVIRUS IMMUNOASSAY INSTRUMENT [Right-click to bookmark this link]
StatusExamination is in progress
Status updated on  18.04.2024
Database last updated on 22.01.2025
FormerRequest for examination was made
Status updated on  09.12.2022
FormerThe international publication has been made
Status updated on  25.10.2021
Most recent event   Tooltip11.10.2024New entry: Despatch of examination report + time limit 
Applicant(s)For all designated states
Denka Company Limited
1-1 Nihonbashi-Muromachi 2-chome
Chuo-ku
Tokyo 103-8338 / JP
[2023/02]
Inventor(s)01 / MIYAZAWA, Takashi
c/o Denka Company Limited, Gosen Site Kagamida
Plant, 1359-1, Aza Kagamida, Kigoshi
Gosen-shi, Niigata 959-1834 / JP
02 / KUWAHARA, Miwa
c/o Denka Company Limited, Gosen Site Kagamida
Plant, 1359-1, Aza Kagamida, Kigoshi
Gosen-shi, Niigata 959-1834 / JP
 [2023/02]
Representative(s)Mewburn Ellis LLP
Aurora Building
Counterslip
Bristol BS1 6BX / GB
[2023/02]
Application number, filing date21789366.815.04.2021
[2023/02]
WO2021JP15541
Priority number, dateJP2020007323916.04.2020         Original published format: JP 2020073239
[2023/02]
Filing languageJA
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2021210633
Date:21.10.2021
Language:JA
[2021/42]
Type: A1 Application with search report 
No.:EP4116324
Date:11.01.2023
Language:EN
[2023/02]
Search report(s)International search report - published on:JP21.10.2021
(Supplementary) European search report - dispatched on:EP04.08.2023
ClassificationIPC:C07K16/08, C07K16/46, C12N15/13, G01N33/569, C12P21/08
[2023/02]
CPC:
C07K16/081 (EP,US); C07K16/2803 (KR); G01N33/56983 (EP,KR,US);
C07K2317/33 (EP); G01N2333/075 (EP,KR,US); G01N2470/04 (US);
Y02A50/30 (EP) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2023/02]
TitleGerman:ADENOVIRUS-IMMUNTESTVERFAHREN UND ADENOVIRUS-IMMUNTESTINSTRUMENT[2023/02]
English:ADENOVIRUS IMMUNOASSAY METHOD AND ADENOVIRUS IMMUNOASSAY INSTRUMENT[2023/02]
French:PROCÉDÉ DE DOSAGE IMMUNOLOGIQUE D'ADÉNOVIRUS ET INSTRUMENT DE DOSAGE IMMUNOLOGIQUE D'ADÉNOVIRUS[2023/02]
Entry into regional phase05.10.2022Translation filed 
05.10.2022National basic fee paid 
05.10.2022Search fee paid 
05.10.2022Designation fee(s) paid 
05.10.2022Examination fee paid 
Examination procedure05.10.2022Examination requested  [2023/02]
01.03.2024Amendment by applicant (claims and/or description)
01.03.2024Date on which the examining division has become responsible
17.04.2024Despatch of a communication from the examining division (Time limit: M04)
12.08.2024Reply to a communication from the examining division
10.10.2024Despatch of a communication from the examining division (Time limit: M04)
Fees paidRenewal fee
24.03.2023Renewal fee patent year 03
22.03.2024Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[X]US4487829  (SHARP PHILLIP A [US], et al);
 [A]JP2007057495  (UNIV TOTTORI, et al);
 [A]JP2008196967  (BL KK);
 [A]EP2161285  (CA MINISTER NAT DEFENCE [CA]);
 [A]WO2015015003  (UNIV CATHOLIQUE LOUVAIN [BE], et al);
 [A]JP2015055487  (DENKA SEIKEN KK);
by applicantJP2000290298
 JP2000290299
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.